<p>IVM (filled squares) or MOX (empty squares) was administered to Mdr1ab(−/−) mice or to wild-type mice at increasing doses. Highest doses used for each ML were below the LD<sub>50</sub> to ensure a non-lethal effect of the administration. Mice in each group were sacrificed 24 h after treatment and drug concentrations were determined in brain and plasma. Absolute brain accumulation was plotted against the administrated dose in (<b>A</b>) Mdr1ab(−/−) or (<b>B</b>) wild-type mice. A positive and significant linear correlation was observed between brain uptake and the administered dose rate (R<sup>2</sup>>0.94 in all cases). All measurements are expressed as mean ± S.D. of six animals.</p
<p>Increase in median survival time (IST<sub>median</sub>; in %), increase in mean survival time (IS...
<p>Mice were treated with 40 mg/kg/day of quinacrine in a chocolate-flavored liquid diet for 31 d an...
<p>Extracellular DA concentration was measured using chronoamperometry after local application of lo...
<p>IVM or MOX was administered to Mdr1ab(−/−) mice (6 per dose rate) or to wild-type mice (3 per dos...
<p>Ivermectin (IVM) or moxidectin (MOX) was administered subcutaneously in Mdr1ab(−/−) mice (6 per d...
<p>Acute toxicity was determined by observing survival during a 14-day period after subcutaneous adm...
<p>The Mdr1ab(−/−) mice (3 per dose rate) injected subcutaneously at dose rates of 0.11, 0.40 and 0....
Pharmacokinetic evaluation of peripheral and brain antibody level following intravenous injection of...
<p><b>(A)</b> Western blots show PrP<sup>Sc</sup> levels in the brains of untreated, MDR<sup>0/0</su...
<p>(A) NeuN-stained cross-sections of the spinal cord at the level L3 to L5. Non-treated controls (S...
Purpose. The effect of P-glycoprotein (Pgp) on brain distribution using mdr1a (-/-) mice was investi...
<p>In WT mice, <b>5a</b> clears from the liver and does not penetrate significantly into the brain, ...
<p>6–8 week old NSG mice (n = 6) were (<b>a</b>), administered MTX by i.p. injection at 25 mg/kg/day...
<p>Serum, brain, and CSF samples were collected at 2 hours after treatment of M084 or vehicle. Conce...
(A) Kaplan-Meier survival curves of MMA mice injected with vehicle or different doses of mLB-001. Lo...
<p>Increase in median survival time (IST<sub>median</sub>; in %), increase in mean survival time (IS...
<p>Mice were treated with 40 mg/kg/day of quinacrine in a chocolate-flavored liquid diet for 31 d an...
<p>Extracellular DA concentration was measured using chronoamperometry after local application of lo...
<p>IVM or MOX was administered to Mdr1ab(−/−) mice (6 per dose rate) or to wild-type mice (3 per dos...
<p>Ivermectin (IVM) or moxidectin (MOX) was administered subcutaneously in Mdr1ab(−/−) mice (6 per d...
<p>Acute toxicity was determined by observing survival during a 14-day period after subcutaneous adm...
<p>The Mdr1ab(−/−) mice (3 per dose rate) injected subcutaneously at dose rates of 0.11, 0.40 and 0....
Pharmacokinetic evaluation of peripheral and brain antibody level following intravenous injection of...
<p><b>(A)</b> Western blots show PrP<sup>Sc</sup> levels in the brains of untreated, MDR<sup>0/0</su...
<p>(A) NeuN-stained cross-sections of the spinal cord at the level L3 to L5. Non-treated controls (S...
Purpose. The effect of P-glycoprotein (Pgp) on brain distribution using mdr1a (-/-) mice was investi...
<p>In WT mice, <b>5a</b> clears from the liver and does not penetrate significantly into the brain, ...
<p>6–8 week old NSG mice (n = 6) were (<b>a</b>), administered MTX by i.p. injection at 25 mg/kg/day...
<p>Serum, brain, and CSF samples were collected at 2 hours after treatment of M084 or vehicle. Conce...
(A) Kaplan-Meier survival curves of MMA mice injected with vehicle or different doses of mLB-001. Lo...
<p>Increase in median survival time (IST<sub>median</sub>; in %), increase in mean survival time (IS...
<p>Mice were treated with 40 mg/kg/day of quinacrine in a chocolate-flavored liquid diet for 31 d an...
<p>Extracellular DA concentration was measured using chronoamperometry after local application of lo...